Treatment of Angioedema

Immediate Assessment and Airway Management

The American College of Allergy, Asthma, and Immunology recommends assessing for airway compromise immediately as this is the most critical first step in managing any patient with angioedema 3
Patients with oropharyngeal or laryngeal involvement should be closely monitored in a medical facility capable of performing intubation or tracheostomy if necessary, as recommended by medical guidelines 3
Consider elective intubation if the patient exhibits signs of impending airway closure, such as change in voice, loss of ability to swallow, or difficulty breathing, according to medical experts 3

Administer epinephrine (0.1%) 0.3 mL subcutaneously or by nebulizer 0.5 mL for significant symptoms or airway involvement, as recommended by the American Academy of Allergy, Asthma, and Immunology 3
Give IV diphenhydramine 50 mg and IV methylprednisolone 125 mg, according to medical guidelines 3
Add H2 blockers such as ranitidine 50 mg IV or famotidine 20 mg IV, as suggested by medical experts 3
For chronic management, use high-dose second-generation H1 antihistamines (fourfold the standard dose), with addition of montelukast if antihistamines alone fail, as recommended by the American College of Allergy, Asthma, and Immunology 2

Administer plasma-derived C1 inhibitor (1000-2000 U intravenously) or icatibant (30 mg subcutaneously) if available, as recommended by the European Academy of Allergy and Clinical Immunology 1, 3
Standard treatments for allergic reactions (antihistamines, corticosteroids, epinephrine) are NOT effective for hereditary angioedema, according to medical guidelines 2
Fresh frozen plasma (10-15 ml/kg) may be considered if specific targeted therapies are unavailable, as suggested by medical experts 3

Immediately discontinue the ACE inhibitor permanently, as recommended by the American Heart Association 3
Consider bradykinin pathway-targeted therapies such as icatibant (30 mg subcutaneously), according to medical guidelines 3

Before dental or surgical procedures, administer plasma-derived C1 inhibitor (1000-2000 U intravenously), as recommended by the European Academy of Allergy and Clinical Immunology 1, 3
Alternative options include attenuated androgens (danazol 2.5-10 mg/kg) or tranexamic acid, according to medical guidelines 4, 1
For high-risk procedures when first-line therapies are unavailable, consider attenuated androgens, fresh frozen plasma, or a combination of both, as suggested by medical experts 4

For patients with frequent attacks, options include androgens (danazol 100 mg on alternate days), as recommended by the American College of Allergy, Asthma, and Immunology 2
Tranexamic acid (30-50 mg/kg/day) should be considered as long-term prophylaxis where first-line treatments are not available, according to medical guidelines 4
Regular monitoring for side effects by blood testing and periodic hepatic ultrasounds should be implemented for patients receiving attenuated androgens, as suggested by medical experts 4

Tranexamic acid should be the preferred drug for long-term prophylaxis in children where first-line agents are unavailable, as recommended by the European Academy of Allergy and Clinical Immunology 4, 3
Fresh frozen plasma should be considered for acute treatment and short-term prophylaxis where first-line agents are unavailable, according to medical guidelines 4
Attenuated androgens may exceptionally be considered for long-term prophylaxis but side effect burden is likely to be high, as suggested by medical experts 4

C1-INH is the only recommended acute and prophylactic treatment for pregnant patients with hereditary angioedema, as recommended by the American College of Obstetricians and Gynecologists 3

Delaying epinephrine administration in cases of airway compromise with histamine-mediated angioedema, as warned by medical guidelines 3
Using standard angioedema treatments (epinephrine, corticosteroids, antihistamines) for bradykinin-mediated angioedema, which are ineffective, according to medical experts 2
Discharging patients with oropharyngeal or laryngeal involvement without adequate observation, as cautioned by medical guidelines 3
Failing to recognize that laryngeal attacks are potentially life-threatening with historical mortality rates of approximately 30% or higher, as emphasized by medical experts 2